Acquired hyporesponsiveness to bacterial lipopolysaccharide and interferon-γ in raw 264.7 macrophages

Shock

Volumn 6, Issue 3, 1996, Pages 218-222

  Richard Boyte, W ^a   Meals, Elizabeth A ^a   English, B Keith ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; INTERFERON-GAMMA, RECOMBINANT; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030227519     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199609000-00011     Document Type: Article

References (35)

1. Parrilo J: Pathogenetic mechanisms of septic shock. N Eng J Med 328: 1471-1477, 1993.
2. Raetz C, Ulevitch R, Wright S, Sibley C, Ding A, Nathan C: Gram-negative endotoxin: An extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 5:2652-2660, 1991.
3. Wright S, Ramos R, Tobias P, Ulevitch R, Mathison J: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433, 1990.
4. Giroir B: Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 21:780-789, 1993.
5. Stone R: Search for sepsis drugs goes on despite past failures. Science 264:365-367, 1994.
6. Novodgrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A: Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322, 1994.
7. Beutler B, Cerami A: The biology of cachectin/TNF: A primary mediator of the host response. Annu Rev Immunol 7:625-655, 1989.
8. Nathan C, Xie Q: Nitric oxide synthase: Roles, tolls, and controls. Cell 78:915-918, 1994.
9. Schmidt HH, Walter U: NO at work. Cell 78:919-925, 1994.
10. Mathison J, Wolfson E, Steinmann S, Tobias P: Lipopolysaccharide recognition in macrophages. J Clin Invest 92:2053-2059, 1993.
11. Zuckerman S, Evans G, Butler L: Endotoxin tolerance: Independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun 59:2774-2780, 1991.
12. Mathison J, Virca G, Wolfson E, Tobias P, Glaser K, Ulevitch R: Adaptation to bacterial lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Inves 85:108-118, 1990.
13. Virca G, Kim S, Glaser K, Ulevitch R: Lipopolysaccharide Induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem 264:21951-21956, 1989.
14. Zhang X, Morrison D: Lipopolysaccharide-induced selective priming effects on tumor necrosis factor and nitric oxide production in mouse peritoneal macrophages. J Exp Med 177:511-516, 1993.
15. Maniatis T, Fritsch E, Sambrook J: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982, pp 187-209.
16. Lewis D, Larson A, Wilson C: Reduced interferon-gamma mRNA levels in human neonates. J Exp Med 163:1018-1023, 1986.
17. Xie Q, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med 177:1779-1784, 1993.
18. Zhang X, Morrison D: Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J Leuk Biol 54:444-450, 1993.
19. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL: Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans in the sepsis syndrome. J Clin Invest 91: 853-858, 1993.
20. Ziegler-Heitbrock HWL, Blumenstein E, Kafferlein E, et al: 1992. In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 expression in a similar fashion. Immunology 75:264-269.
21. Granowitz EV, Porat R, Mier JW, et al: Intravenous endotoxin suppresses the cytokine response to peripheral blood mononuclear cells of healthy humans. J Immunol 151:1637-1645, 1993.
22. Vogel SN, Kaufman EN, Tate MD, Neta R: Recombinant interleukin-1α and recombinant tumor necrosis factor α synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 56:2650-2657, 1988.
23. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267:23301-23308, 1992.
24. Cavaillon JM, Pitton C, Fitting C: Endotoxin tolerance is not a LPS-specific phenomenon: Partial mimicry with IL-1, IL-10, and TGF-β. J Endotox Res 1:21-29, 1994.
25. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR: Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance. Proc Natl Acad Sci USA 91:271-275, 1994.
26. Eigler A, Moeller J, Endres S: Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol 154:4048-4054, 1995.
27. Haas JG, Meyer N, Riethmuller G, Ziegler-Heitbrock HWL: Inhibition of lipopolysaccharide-induced in vitro desensitization by inteferon-γ. Eur J Immunol 20:1181-1184, 1990.
28. Adi S, Pollock AS, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Role for monokines in the metabolic effects of endotoxin: Inteferon-gamma restores responsiveness of C3H/HeJ mice in vivo. J Clin Invest 89:1603-1609, 1992.
29. Faggioni R, Fantuzzi G, Villa P, Buurman W. vanTits LJH, Ghezzi P: Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun 63:1473-1477, 1995.
30. LaRue KEA, McCall CE: A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med 180:2269-2275, 1994.
31. d) mice respond to bacterial lipopolysaccharide by activating NF-κB. J Leuk Biol 57:174-179, 1995.
32. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O: Signaling by the cytokine receptor superfamily: JAKs and STATs. TIBS 19:222-227, 1994.
33. English BK, Ihle JN, Myracle A, Yi T (1993) Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J Exp Med 178:1017-1022, 1994.
34. Beaty CD, Franklin TL, Uehara Y, Wilson CB: Lipopolysaccharide-induced cytokine production in human monocytes: Role of tyrosine phosphorylation in transmembrane signal transduction. Eur J Immunol 24: 1278-1284, 1994.
35. English BK: Bacterial lipopolysaccharide and interferon-gamma trigger the prompt tyrosine phosphorylation of vav in RAW 264.7 macrophages. J Cellular Biochem 19A:A1-A123 (abstract), 1995.